Cited by 319Metabolism, Diabetes, and CancerDiabetes Treatment and ManagementGlycogen Storage Diseases and Myoclonus

The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.

Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase

Open access

Hunter, Roger W., Hughey, Curtis C., Lantier, Louise, Sundelin, Elias I., Peggie, Mark, Zeqiraj, Elton, Sicheri, Frank, Jessen, Niels, Wasserman, David H., Sakamoto, Kei·2018·Nature Medicine

DOI 10.1038/s41591-018-0159-7PMC PMC6207338

Open this paper in CoChat — free account Open PDF

Abstract

Metformin is a first-line drug for the treatment of individuals with type 2 diabetes, yet its precise mechanism of action remains unclear. Metformin exerts its antihyperglycemic action primarily through lowering hepatic glucose production (HGP). This suppression is thought to be mediated through inhibition of mitochondrial respiratory complex I, and thus elevation of 5′-adenosine monophosphate (AMP) levels and the activation of AMP-activated protein kinase (AMPK), though this proposition has been challenged given results in mice lacking hepatic AMPK. Here we report that the AMP-inhibited enzyme fructose-1,6-bisphosphatase-1 (FBP1), a rate-controlling enzyme in gluconeogenesis, functions as a major contributor to the therapeutic action of metformin. We identified a point mutation in FBP1 that renders it insensitive to AMP while sparing regulation by fructose-2,6-bisphosphate (F-2,6-P2), and knock-in (KI) of this mutant in mice significantly reduces their response to metformin treatment. We observe this during a metformin tolerance test and in a metformin-euglycemic clamp that we have developed. The antihyperglycemic effect of metformin in high-fat diet–fed diabetic FBP1-KI mice was also significantly blunted compared to wild-type controls. Collectively, we show a new mechanism of action for metformin and provide further evidence that molecular targeting of FBP1 can have antihyperglycemic effects. The antidiabetic action of metformin raises heptocyte intracellular AMP levels, causing allosteric inhibition of fructose-1,6-bisphosphatase and thus reductions in gluconeogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41591-018-0159-7

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Methods of Enzymatic Analysis
(1975) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/58.5.1085 · Cited by 20,078
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Anorexigenic and Orexigenic Hormone Modulation of Mammalian Target of Rapamycin Complex 1 Activity and the Regulation of Hypothalamic Agouti-Related Protein mRNA Expression
Watterson, K. R., Bestow, D., Gallagher, J. R., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2012) · Neurosignals · doi:10.1159/000334144 · Cited by 3,395
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
[1] Citrate synthase
Srere, P. A. (1969) · Methods in Enzymology · doi:10.1016/0076-6879(69)13005-0 · Cited by 2,005
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Mannerås-Holm, L., Ståhlman, M., Olsson, L. M., Serino, M., Planas-Fèlix, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4345 · Cited by 1,632
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399

Show all 86 references

Research works printed but not linked: 1

Noll, F. Methods of Enzymatic Analysis 3rd edn, Vol. 6 (ed. Bergmeyer, H. U.) 582–588 (Verlag Chemie, Weinheim, Germany, 1984).

Sorted by citations

Items 101–200 of 319

The Hormetic Effect of Metformin: “Less Is More”?
Panfoli, I., Puddu, A., Bertola, N., Ravera, S., & Maggi, D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126297 · Cited by 29
Hyperglycemia-driven signaling bridges between diabetes and cancer
Ghareghomi, S., Arghavani, P., Mahdavi, M., Khatibi, A., García‐Jiménez, C., & Moosavi‐Movahedi, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116450 · Cited by 29
In vivo 2H/13C flux analysis in metabolism research
Bednarski, T. K., Rahim, M., & Young, J. D. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.04.005 · Cited by 26
From Diabetes to Atherosclerosis: Potential of Metformin for Management of Cardiovascular Disease
Poznyak, A. V., Litvinova, L. S., Poggio, P., Moschetta, D., Sukhorukov, V. N., & Orekhov, A. N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179738 · Cited by 27
The interaction between metformin and physical activity on postprandial glucose and glucose kinetics: a randomised, clinical trial
Pilmark, N. S., Lyngbæk, M. P. P., Oberholzer, L., Elkjær, I., Petersen-Bønding, C., Kofoed, K., Siebenmann, C., Kellenberger, K., van Hall, G., Abildgaard, J., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05282-6 · Cited by 26
TNFSF14+ natural killer cells prevent spontaneous abortion by restricting leucine-mediated decidual stromal cell senescence
Shi, J., Lai, Z., Zhou, W., Yang, H., Zhang, T., Sun, J., Zhao, J., & Li, M. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00220-3 · Cited by 27
Metformin Targets Foxo1 to Control Glucose Homeostasis
Guo, X., Li, X., Yang, W., Liao, W., Shen, Z., Ai, W., Pan, Q., Sun, Y., Zhang, K., Zhang, R., et al. (2021) · Biomolecules · doi:10.3390/biom11060873 · Cited by 24
A Single Dose of Oral Metformin Reduces the Post-Prandial Glucose Response Through a Transient Modulation of Apical Sodium-Glucose Co-Transporter
Zubiaga, L., Briand, O., Auger, F., Touche, V., Hübert, T., Thévenet, J., Marciniak, C., Quenon, A., Bonner, C., Peschard, S., et al. (2019) · iScience · doi:10.1016/j.isci.2023.106057 · Cited by 28
Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question
Tocci, V., Mirabelli, M., Salatino, A., Sicilia, L., Giuliano, S., Brunetti, F. S., CHIEFARI, E. D., Sarro, G. D., FOTI, D. P., & Brunetti, A. (2023) · Pharmaceuticals · doi:10.3390/ph16091318 · Cited by 31
Novel and emerging therapeutic drug targets for management of type 2 Diabetes Mellitus
Sharma, P., Singh, S., Thakur, V., Sharma, N., & Grewal, A. S. (2021) · Obesity Medicine · doi:10.1016/j.obmed.2021.100329 · Cited by 27
Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area
Tulipano, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313068 · Cited by 26
Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus
Azizogli, A., Vitti, M., Mishra, R., Osorno, L., Heffernan, C., & Kumar, V. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300143 · Cited by 28
Chrysin-loaded PEGylated liposomes protect against alloxan-induced diabetic neuropathy in rats: the interplay between endoplasmic reticulum stress and autophagy
El-Emam, M. M. A., Behairy, A., Mostafa, M., Khamis, T., Osman, N. M. S., Alsemeh, A. E., & Mansour, M. F. (2024) · Biological Research · doi:10.1186/s40659-024-00521-1 · Cited by 26
A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity
Vila, I. K., Park, M. K., Setijono, S. R., Yao, Y., Kim, H., Badin, P.-M., Choi, S., Narkar, V. A., Choi, S., Chung, J., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.128269 · Cited by 23
Overexpression of long noncoding RNA ANRIL inhibits phenotypic switching of vascular smooth muscle cells to prevent atherosclerotic plaque development in vivo
Hu, D., Li, Z., Zhu, Y.-T., & Li, C. (2020) · Aging · doi:10.18632/aging.202392 · Cited by 25
Advances in the Insulin–Heart Axis: Current Therapies and Future Directions
Caturano, A., Vetrano, E., Galiero, R., Sardu, C., Rinaldi, L., Russo, V., Monda, M., Marfella, R., & Sasso, F. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810173 · Cited by 24
Phosphorus Heterocycles and Their Biological Applications
Kumar, A., Mukhopadhyay, J., & Bhagat, S. (2024) · ChemistrySelect · doi:10.1002/slct.202404258 · Cited by 22
Metformin suppresses cardiac fibroblast proliferation under high-glucose conditions via regulating the mitochondrial complex I protein Grim-19 involved in the Sirt1/Stat3 signaling pathway
Li, Y., Liu, X., Wan, L., Han, B., Ma, S., Pan, H., Wei, J., & Cui, X. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.06.013 · Cited by 24
Chemerin and Dermcidin in Human Milk and Their Alteration in Gestational Diabetes
Üstebay, S., Baykuş, Y., Deniz, R., Uğur, K., Yavuzkır, Ş., Yardım, M., Kalaycı, M. Z., Çağlar, M., & Aydın, S. (2019) · Journal of Human Lactation · doi:10.1177/0890334419837523 · Cited by 22
AMPK and the Need to Breathe and Feed: What’s the Matter with Oxygen?
Evans, A. M., & Hardie, D. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103518 · Cited by 21
The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis
Aung, M., Amin, S., Gulraiz, A., Gandhi, F. R., Escobar, J. A. P., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.10412 · Cited by 21
Metformin alleviates irradiation-induced intestinal injury by activation of FXR in intestinal epithelia
Yang, J.-Y., Liu, M., Lv, L. L., Guo, J.-R., He, K.-Y., Zhang, H., Wang, K., Cui, C.-Y., Yan, B., Du, D., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.932294 · Cited by 21
Mechanisms and effects of metformin on skeletal muscle disorders
Shang, R., & Miao, J. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1275266 · Cited by 23
Hepatic exposure of metformin in patients with non‐alcoholic fatty liver disease
Sundelin, E. I. O., Gormsen, L. C., Heebøll, S., Vendelbo, M. H., Jakobsen, S., Munk, O. L., Feddersen, S., Brøsen, K., Hamilton-Dutoit, S. J., Pedersen, S. B., et al. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13962 · Cited by 21
Self-citation
N -Acylamino Saccharin as an Emerging Cysteine-Directed Covalent Warhead and Its Application in the Identification of Novel FBPase Inhibitors toward Glucose Reduction
Wen, W., Cao, H., Xu, Y., Ren, Y., Rao, L., Shao, X., Chen, H., Wu, L., Liu, J., Chen, S., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00336 · Cited by 20
Alleviation of Liver Fibrosis Via Hepatic Stellate Cells Mitochondrial Apoptosis Induced by Metformin
Su, Y., Lu, S., Hou, C., Ren, K., Wang, M., Liu, X., Zhao, S., & Liu, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108683 · Cited by 21
Abelmoschus esculentus (L.) Moench Pod Extract Revealed Antagonistic Effect against the Synergistic Antidiabetic Activity of Metformin and Acarbose upon Concomitant Administration in Glucose-Induced Hyperglycemic Mice
Haque, M. A., Hossain, M. S., Sayed, N. M. A., Islam, M. T., Khan, M. R., Ahmmed, F., Zohora, F. T., Ağagündüz, D., Ming, L. C., & Capasso, R. (2022) · Biologics · doi:10.3390/biologics2020010 · Cited by 20
Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite–binding site
Sanders, M. J., Ratinaud, Y., Neopane, K., Bonhoure, N., Day, E. A., Ciclet, O., Lassueur, S., Pinta, M. N., Deák, M., Brinon, B., et al. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101852 · Cited by 20
Self-citation
Metformin: A Promising Antidiabetic Medication for Cancer Treatment
Mu, W., Jiang, Y., Liang, G., Feng, Y., & Qu, F. (2022) · Current Drug Targets · doi:10.2174/1389450124666221104094918 · Cited by 18
TMT-based quantitative proteomics analysis reveals the differential proteins between fresh and frozen-thawed sperm of yak (Bos grunniens)
Fan, Y., Li, X., Guo, Y. M., He, X., Wang, Y., Zhao, D., Ma, Y., Feng, X., Zhang, J., Zi, X., et al. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.01.024 · Cited by 19
Nutritional Factors: Benefits in Glaucoma and Ophthalmologic Pathologies
Musa, M., Zeppieri, M., Atuanya, G. N., Enaholo, E. S., Topah, E. K., Ojo, O. M., & Salati, C. (2023) · Life · doi:10.3390/life13051120 · Cited by 20
Shear Stress-Induced AMP-Activated Protein Kinase Modulation in Endothelial Cells: Its Role in Metabolic Adaptions and Cardiovascular Disease
Hauger, P. C., & Hordijk, P. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116047 · Cited by 21
Phenyllactic acid modulates the gut microbiota, enhances intestinal health, and alleviates physical frailty in aging mice
Kim, D., Xu, H., Li, O., Xue, M., Bao, Z., & Yang, F. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177105 · Cited by 17
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study
Larsen, A. H., Wiggers, H., Dollerup, O. L., Jespersen, N. R., Hansson, N. H., Frøkiær, J., Brøsen, K., Nørrelund, H., Bøtker, H. E., Møller, N., et al. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07050-5 · Cited by 17
Self-citation
Metformin action in the gut―insight provided by [18F]FDG PET imaging
Tsuchida, H., Morita, Y., Nogami, M., & Ogawa, W. (2021) · Diabetology International · doi:10.1007/s13340-021-00545-y · Cited by 16
Metformin extends the chronological lifespan of fission yeast by altering energy metabolism and stress resistance capacity
Şeylan, C., & Tarhan, Ç. (2023) · FEMS Yeast Research · doi:10.1093/femsyr/foad018 · Cited by 18
Metformin inhibits the progression of castration-resistant prostate cancer by regulating PDE6D induced purine metabolic alternation and cGMP / PKG pathway activation
Cai, S., Deng, Y., Zou, Z., Tian, W., Tang, Z., Li, J., Tan, Z., Wu, Z., Han, Z., Wen, B., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217694 · Cited by 18
Ursolic acid regulates gut microbiota and corrects the imbalance of Th17/Treg cells in T1DM rats
Chen, W., Yu, Y., Liu, Y., Song, C., Chen, H., Tang, C., Song, Y., & Zhang, X. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277061 · Cited by 18
Lactobacillus helveticus Isolated from Raw Milk Improves Liver Function, Hepatic Steatosis, and Lipid Metabolism in Non-Alcoholic Fatty Liver Disease Mouse Model
Kim, H., Lee, K., Kim, J., Shim, J.-J., Lim, J., Kim, J.-Y., & Lee, J.-L. (2023) · Microorganisms · doi:10.3390/microorganisms11102466 · Cited by 16
Is metformin a geroprotector? A peek into the current clinical and experimental data
Zajda, A., Huttunen, K. M., Sikora, J., Podsiedlik, M., & Markowicz-Piasecka, M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111350 · Cited by 16
FBP1 induced by β‐elemene enhances the sensitivity of gefitinib in lung cancer
Li, J., Dai, P., Sun, J., Yu, W., Han, W., & Li, K. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14750 · Cited by 15
Probing mitochondrial metabolism in vivo
McElroy, G. S., & Chandel, N. S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819614116 · Cited by 15
A milk casein hydrolysate‐derived peptide enhances glucose uptake through the AMP‐activated protein kinase signalling pathway in skeletal muscle cells
Iwasa, M., Takezoe, S., Kitaura, N., Sutani, T., Miyazaki, H., & Aoi, W. (2020) · Experimental Physiology · doi:10.1113/ep088770 · Cited by 15
A blast from the past: To tame time with metformin
Xenos, D., Mecocci, P., & Boccardi, V. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111743 · Cited by 15
Metformin: still the sweet spot for CV protection in diabetes?
Rena, G., Mordi, I. R., & Lang, C. C. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.10.018 · Cited by 15
Metformin as a potential antidepressant: Mechanisms and therapeutic insights in depression
Cheng, Y., Yao, Q. Z., Miao, Y., & Guan, W. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116773 · Cited by 16
Proteomic Analysis Reveals That Metformin Suppresses PSMD2, STIP1, and CAP1 for Preventing Gastric Cancer AGS Cell Proliferation and Migration
Wang, W.-H., Chen, S.-K., Huang, H., & Juan, H. (2021) · ACS Omega · doi:10.1021/acsomega.1c00894 · Cited by 15
Effects of Metformin on Ischemia/Reperfusion Injury: New Evidence and Mechanisms
Osorio-Llanes, E., Villamizar-Villamizar, W., Ospino-Guerra, M. C., Díaz-Ariza, L. A., Castiblanco-Arroyave, S. C., Medrano, L., Mengual, D., Belón, R., Castellar-López, J., Sepulveda, Y., et al. (2023) · Pharmaceuticals · doi:10.3390/ph16081121 · Cited by 20
Metformin in gestational diabetes: physiological actions and clinical applications
Mason, T., Alesi, S., Fernando, M., Vanky, E., Teede, H. J., & Mousa, A. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01049-w · Cited by 19
Two-Photon Cellular and Intravital Imaging of Hypochlorous Acid by Fluorescent Probes That Exhibit a Synergistic Excited-State Intramolecular Proton Transfer–Intramolecular Charge Transfer Mechanism Enabling Near-Infrared Emission with a Large Stokes Shift
Long, Y., Liu, J., Ju, Z., Qi, F., Tang, W., Yan, S., Dai, F., Zhang, S., & Zhou, B. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04075 · Cited by 14
Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway
Zhang, X., Zhuang, Y., Qin, T., Chang, M., Ji, X., Wang, N., Zhang, Z., Zhou, H., Wang, Q., & Li, J. Z. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154823 · Cited by 14
AMPK deficiency in smooth muscles causes persistent pulmonary hypertension of the new-born and premature death
Moral‐Sanz, J., Lewis, S. A., MacMillan, S., Meloni, M., McClafferty, H., Viollet, B., Foretz, M., del Pozo, J., & Evans, A. M. (2022) · Nature Communications · doi:10.1038/s41467-022-32568-7 · Cited by 14
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
Abdelmoneim, M., Eissa, I. R., Aboalela, M. A., Naoe, Y., Matsumura, S., Sibal, P. A., Bustos‐Villalobos, I., Tanaka, M., Kodera, Y., & Kasuya, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-25065-w · Cited by 14
Two isoprenylated flavonoids from Dorstenia psilurus activate AMPK, stimulate glucose uptake, inhibit glucose production and lower glycemia
Choumessi, A. T., Johanns, M., Beaufay, C., Hérent, M., Stroobant, V., Vertommen, D., Corbet, C., Jacobs, R., Herinckx, G., Steinberg, G. R., et al. (2019) · Biochemical Journal · doi:10.1042/bcj20190326 · Cited by 15
G protein-coupled receptor 151 regulates glucose metabolism and hepatic gluconeogenesis
Bielczyk-Maczyńska, E., Zhao, M., Zushin, P. H., Schnurr, T. M., Kim, H.-J., Li, J., Nallagatla, P., Sangwung, P., Park, C. Y., Cornn, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35069-9 · Cited by 13
Redox state and altered pyruvate metabolism contribute to a dose-dependent metformin-induced lactate production of human myotubes
Maurer, J. A., Zhao, X., Irmler, M., Gudiksen, A., Pilmark, N. S., Li, Q., Goj, T., Beckers, J., de Angelis, M. H., Birkenfeld, A. L., et al. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00186.2023 · Cited by 14
Effect of dapagliflozin on proteomics and metabolomics of serum from patients with type 2 diabetes
Liu, J., Chang, X., Ding, X., He, X., Wang, J., & Wang, G. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01229-0 · Cited by 15
Metformin Effects on SHIP2, AMPKs and Gut Microbiota: Recent Updates on Pharmacology
Shivaprakash, P., Beeraka, N. M., Madhunapantula, S. V., Nikolenko, V. N., & Basalingappa, K. M. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673289342240213040144 · Cited by 14
Improvement of Theaflavins on Glucose and Lipid Metabolism in Diabetes Mellitus
Xu, S., Chen, Y., & Gong, Y. (2024) · Foods · doi:10.3390/foods13111763 · Cited by 15
Dreh, a long noncoding RNA repressed by metformin, regulates glucose transport in C2C12 skeletal muscle cells
Takahashi, N., Kimura, A. P., Otsuka, K., Ohmura, K., Naito, S., Yoshida, M., & Ieko, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116906 · Cited by 14
Transcriptomic landscape profiling of metformin‐treated healthy mice: Implication for potential hypertension risk when prophylactically used
Meng, Y., Xiang, R., Yan, H., Zhou, Y., Hu, Y., Yang, J., Zhou, Y., & Cui, Q. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15472 · Cited by 14
Loss of TSC complex enhances gluconeogenesis via upregulation of Dlk1-Dio3 locus miRNAs
Liko, D., Rzepiela, A. J., Vukojević, V., Zavolan, M., & Hall, M. N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1918931117 · Cited by 13
The parasite-derived peptide FhHDM-1 activates the PI3K/Akt pathway to prevent cytokine-induced apoptosis of β-cells
Camaya, I., Mok, T. Y., Lund, M. E., To, J., Braidy, N., Robinson, M. W., Santos, J., O’Brien, B. A., & Donnelly, S. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02122-x · Cited by 12
The proteomic characteristics of airway mucus from critical ill COVID-19 patients
Zhang, Z., Wang, T., Liu, F., Zhu, A., Gu, G., Luo, J., Xu, J., Zhao, J., Li, Y., Li, Y., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119046 · Cited by 12
From Diabetes to Degenerative Diseases: The Multifaceted Action of Metformin
Campagnoli, L. I. M., Varesi, A., Fahmideh, F., Hakimizad, R., Petkovic, P., Barbieri, A., Marchesi, N., & Pascale, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199748 · Cited by 15
Metformin—mechanisms of its glycemia-reducing effect
Drewe, J., Foretz, M., & Krähenbühl, S. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100106 · Cited by 18
Extensive therapeutic effects, underlying molecular mechanisms and disease treatment prediction of Metformin: a systematic review
Geng, Y., Wang, Z., Xu, X., Sun, X., Dong, X., Luo, Y., & Sun, X. (2023) · Translational research · doi:10.1016/j.trsl.2023.08.001 · Cited by 13
Inhibition of hepatic gluconeogenesis in type 2 diabetes by metformin: complementary role of nitric oxide
Farahani, A., Farahani, A., Kashfi, K., & Ghasemi, A. (2025) · Medical Gas Research · doi:10.4103/mgr.medgasres-d-24-00100 · Cited by 13
Major Advances and Discoveries in Diabetes - 2019 in Review
Zierath, J. R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1255-x · Cited by 13
Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review
Alfaraidi, H., & Samaan, M. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1072879 · Cited by 12
Why do some glucose‐lowering agents improve non‐alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis
Ciccarelli, G., Giuseppe, G. D., Cinti, F., Moffa, S., Mezza, T., & Giaccari, A. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3668 · Cited by 11
Current status and frontier tracking of clinical trials on Metformin for cancer treatment
Wu, Z., Wang, W., Wei, L., & Zhu, S. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05391-w · Cited by 11
Metformin Increases Protein Phosphatase 2A Activity in Primary Human Skeletal Muscle Cells Derived from Lean Healthy Participants
Mestareehi, A., Zhang, X., Seyoum, B., Msallaty, Z., Mallisho, A., Burghardt, K. J., Kowluru, A., & Yi, Z. (2021) · Journal of Diabetes Research · doi:10.1155/2021/9979234 · Cited by 11
Inhibition of Gluconeogenesis by Boldine in the Perfused Liver: Therapeutical Implication for Glycemic Control
Silva, L. C. L., de Souza, G. H., Pateis, V. D. O., Ames-Sibin, A. P., Silva, B. P., Bracht, L., Comar, J. F., Peralta, R. M., Bracht, A., & de Sá‐Nakanishi, A. B. (2023) · International Journal of Hepatology · doi:10.1155/2023/1283716 · Cited by 11
Phosphorus-Containing Alkynes in the Synthesis of Heterocyclic Compounds (A Review)
Sokolov, A. A., Egorov, D. M., Dogadina, A. V., & Svintsitskaya, N. I. (2024) · Russian Journal of General Chemistry · doi:10.1134/s1070363224030095 · Cited by 10
Low-dose metformin requires brain Rap1 for its antidiabetic action
Lin, H., Lu, W., He, Y., Fu, Y., Kaneko, K., Huang, P., la Puente-Gomez, A. B. D., Wang, C., Yang, Y., Li, F., et al. (2025) · Science Advances · doi:10.1126/sciadv.adu3700 · Cited by 13
Amino acid homeostasis is a target of metformin therapy
Forteath, C., Mordi, I. R., Nisr, R. B., Gutierrez-Lara, E. J., Alqurashi, N., Phair, I. R., Cameron, A., Beall, C., Bahr, I., Mohan, M., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101750 · Cited by 11
Self-citation
Efficacy of metformin and electrical pulses in breast cancer MDA-MB-231 cells
Sahu, P., Camarillo, I. G., & Sundararajan, R. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00204 · Cited by 10
Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice
Ziegler, N., Raichur, S., Brunner, B., Hemmann, U., Stolte, M., Schwahn, U., Prochnow, H.-P., Metz-Weidmann, C., Tennagels, N., Margerie, D., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00598 · Cited by 10
Propionic acid/FBP1 is involved in polystyrene nanoplastic-induced cardiac injury via the gut-heart axis
Kang, H., Huang, D., Zhang, W., Wang, J., Liu, Z., Wang, Z., Jiang, G., & Gao, A. (2025) · Particle and Fibre Toxicology · doi:10.1186/s12989-025-00626-9 · Cited by 11
Inhibition of basal and glucagon-induced hepatic glucose production by 991 and other pharmacological AMPK activators
Johanns, M., Corbet, C., Jacobs, R., Drappier, M., Bommer, G. T., Herinckx, G., Vertommen, D., Tajeddine, N., Young, D., Messens, J., et al. (2022) · Biochemical Journal · doi:10.1042/bcj20220170 · Cited by 9
Prominent and emerging anti-diabetic molecular targets
Almasi, F., & Mohammadipanah, F. (2020) · Journal of drug targeting · doi:10.1080/1061186x.2020.1859517 · Cited by 10
Metformin-associated Lactic Acidosis with Hypoglycemia during the COVID-19 Pandemic
Takayama, K., Obata, Y., Maruo, Y., Yamaguchi, H., Kosugi, M., Irie, Y., Hazama, Y., & Yasuda, T. (2022) · Internal Medicine · doi:10.2169/internalmedicine.9179-21 · Cited by 10
Fructose-1,6-bisphosphatase 1 in cancer: Dual roles, mechanistic insights, and therapeutic potential – A comprehensive review
Song, Q., Sui, J., Yang, Y., Zhang, H., Li, Y., & Yang, L. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.139273 · Cited by 9
Metformin: Antidiabetic actions from cells to tissues
Bailey, C. J., Gwilt, M., & Brand, K. M. G. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156589 · Cited by 10
Biological evaluation and SAR analysis of novel covalent inhibitors against fructose-1,6-bisphosphatase
Han, X., Huang, Y., Wei, L., Chen, H., Guo, Y., Tang, Z., Hu, W., Xia, Q., Wang, Q., Yan, J., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115624 · Cited by 8
Deciphering metformin action in obese mice: A critical re-evaluation of established protocols
Kaplanian, M., Philippe, C., Eid, S. A., Hackl, M. T., Metz, M., Beghini, M., Luca, A. C., Kautzky‐Willer, A., Scherer, T., & Fürnsinn, C. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154956 · Cited by 8
Integrated Analysis of Gut Microbiome and Adipose Transcriptome Reveals Beneficial Effects of Resistant Dextrin from Wheat Starch on Insulin Resistance in Kunming Mice
Chen, X., Hou, Y., Liao, A., Pan, L., Yang, S., Liu, Y., Wang, J. J., Xue, Y., Zhang, M., Zhu, Z., et al. (2024) · Biomolecules · doi:10.3390/biom14020186 · Cited by 10
Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart
Heinz, S., Freyberger, A., Lawrenz, B., Schladt, L., Schmuck, G., & Ellinger-Ziegelbauer, H. C. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02519-1 · Cited by 8
Commentary: Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration—A Mass Spectrometry Imaging Study of the Perfused Rat Liver
Glossmann, H. H., & Lutz, O. M. D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00090 · Cited by 8
Beyond diabetes: harnessing the power of metformin in burn care
Khalaf, F., Touma, D., Saldanha, S., Khalaf, G., Barayan, D., & Jeschke, M. G. (2025) · Critical Care · doi:10.1186/s13054-025-05662-7 · Cited by 9
AMPK promotes TFEB transcriptional activity through dephosphorylation at both MTORC1-dependent and -independent sites
Negoita, F., Bringas, C. F., Hellberg, K., Luda, K. M., Liu, H., Li, Z., Cuenco, J., Zhao, J., Sathe, G. J., Ganley, I. G., et al. (2026) · Autophagy · doi:10.1080/15548627.2026.2629720 · Cited by 7
Self-citation
Real-time monitoring of glucose metabolism and effects of metformin on HepG2 cells using 13C in-cell NMR spectroscopy
Teng, M., Li, Z., Gu, Y., Fan, Y., Wang, D., Liu, M., Li, Y., Wei, G., & Huang, Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149383 · Cited by 7
The pro-drug C13 activates AMPK by two distinct mechanisms
Freemantle, J. B., Shah, D. S., Lynch, D. M., Ciulli, A., Hundal, H. S., & Hardie, D. G. (2024) · Biochemical Journal · doi:10.1042/bcj20240425 · Cited by 7
Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity
Qiao, A., Ma, W., Jiang, Y., Han, C., Yan, B., Zhou, J., & Qin, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911469 · Cited by 6
Early and advanced glycation end product analysis from women with PCOS on metformin
Ambekar, A. S., Naredi, N., Malakar, D., Vashum, Y., Misra, P., & Kulkarni, M. J. (2025) · Reproductive Biology · doi:10.1016/j.repbio.2024.100993 · Cited by 6
Metabolomic changes in the liver tissues of cows in early lactation supplemented with dietary rumen-protected glucose during the transition period
Li, X. P., Tan, Z., Li, Z. C., Gao, S., Yi, K. L., Zhou, C. S., Tang, S., & Han, X. (2021) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2021.115093 · Cited by 6
Molecular Liver Fingerprint Reflects the Seasonal Physiology of the Grey Mouse Lemur (Microcebus murinus) during Winter
Chazarin, B., Benhaim-Delarbre, M., Brun, C., Anzeraey, A., Bertile, F., & Terrien, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084254 · Cited by 5
Genetic and Pharmacological Inhibition of GCN2 Ameliorates Hyperglycemia and Insulin Resistance in Type 2 Diabetic Mice
Yuan, J.-T., Li, F., Shen, X., Gao, J., Yu, Z., Luo, K., Cui, B., & Lu, Z. (2022) · Antioxidants · doi:10.3390/antiox11081584 · Cited by 6
Targeting Tumor Hypoxia
Skwarski, M., Bowler, E., Wilson, J. D., Higgins, G. S., & Hammond, E. M. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_11 · Cited by 7

Authors: Hunter, R. W., Hughey, C. C., Lantier, L., Sundelin, E. I., Peggie, M., Zeqiraj, E., Sicheri, F., Jessen, N., Wasserman, D. H., & Sakamoto, K.
Affiliations: University of Bristol (GB)
Vanderbilt University (US)
Aarhus University (DK)
University of Dundee (GB)
Mount Sinai Hospital (CA)
Corresponding author: Sakamoto, Kei
ORCID: Hunter, Roger W.
Hughey, Curtis C.
Lantier, Louise
Sundelin, Elias I.
Peggie, Mark
Zeqiraj, Elton
Sicheri, Frank
Jessen, Niels
Wasserman, David H.
Sakamoto, Kei
Venue: Nature Medicine
Publisher: Springer Science and Business Media LLC
Published: 2018-08-27
Volume: 24
Issue: 9
Pages: 1395-1406
ISSN: 1078-8956 (ISSN-L)
1546-170X
DOI: 10.1038/s41591-018-0159-7
PMC: PMC6207338
OpenAlex: W2888330909
Cited by: 313
References: 86
Citations by year: 2026: 25 · 2025: 33 · 2024: 47 · 2023: 53 · 2022: 49 · 2021: 33 · 2020: 43 · 2019: 26 · 2018: 4
FWCI: 9.51
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
Locations: Nature Medicine (publishedVersion)
PubMed (publishedVersion)
Discovery Research Portal (University of Dundee) (publishedVersion)
Explore Bristol Research (publishedVersion, other-oa)
White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Bristol Research (University of Bristol) (submittedVersion, other-oa)
Funders: Vanderbilt University (DK059637)
Wellcome Trust (092381)
Novo Nordisk
Danmarks Frie Forskningsfond (4183-00384)
Novo Nordisk Fonden (NNF13OC0003882, NNF17SA0031230-1)
Canadian Institutes of Health Research (143277)
National Institute of Diabetes and Digestive and Kidney Diseases (U2CDK059637, U24DK059637, R37DK050277, P30DK058404)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
Keywords: metformin, FBP1, hepatic glucose production, gluconeogenesis, AMPK, fructose-2,6-bisphosphate, type 2 diabetes, high-fat diet, euglycemic clamp
MeSH terms: Adenosine Monophosphate, Aminoimidazole Carboxamide, Animals, Base Sequence, Chickens, Disease Models, Animal, Glucose, Fructose-Bisphosphatase, Homeostasis, Humans, Hypoglycemia, Liver, Metformin, Mice, Inbred C57BL, Mutation, Obesity, Prodrugs, Ribonucleotides, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks